Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 26 | 2024 | 11695 | 2.310 |
Why?
|
Genetic Predisposition to Disease | 23 | 2024 | 17400 | 1.160 |
Why?
|
Mitoguazone | 1 | 2024 | 10 | 0.980 |
Why?
|
Multifactorial Inheritance | 6 | 2024 | 1190 | 0.940 |
Why?
|
Genetic Loci | 6 | 2024 | 2572 | 0.850 |
Why?
|
Genome-Wide Association Study | 23 | 2024 | 12220 | 0.780 |
Why?
|
Polymorphism, Single Nucleotide | 18 | 2023 | 15494 | 0.750 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2024 | 369 | 0.710 |
Why?
|
Glucokinase | 1 | 2020 | 103 | 0.700 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2023 | 3336 | 0.650 |
Why?
|
Diabetes Mellitus | 5 | 2023 | 5724 | 0.630 |
Why?
|
Pathology, Molecular | 1 | 2021 | 325 | 0.620 |
Why?
|
Diabetes, Gestational | 3 | 2020 | 1184 | 0.560 |
Why?
|
Multigene Family | 1 | 2018 | 1102 | 0.510 |
Why?
|
Hyperglycemia | 2 | 2023 | 1368 | 0.510 |
Why?
|
Insulin Resistance | 4 | 2023 | 3861 | 0.490 |
Why?
|
Dyslipidemias | 1 | 2021 | 848 | 0.470 |
Why?
|
Pharmaceutical Preparations | 1 | 2022 | 1071 | 0.460 |
Why?
|
Apolipoproteins | 1 | 2014 | 315 | 0.420 |
Why?
|
Genetic Variation | 6 | 2023 | 6540 | 0.420 |
Why?
|
Cluster Analysis | 4 | 2024 | 2713 | 0.400 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2010 | 187 | 0.400 |
Why?
|
Genotype | 10 | 2023 | 12946 | 0.370 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 637 | 0.370 |
Why?
|
Electronic Health Records | 2 | 2023 | 4440 | 0.340 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2010 | 355 | 0.320 |
Why?
|
Genetic Testing | 1 | 2021 | 3439 | 0.320 |
Why?
|
Algorithms | 3 | 2023 | 13853 | 0.300 |
Why?
|
Phenotype | 10 | 2022 | 16331 | 0.300 |
Why?
|
Open Reading Frames | 2 | 2021 | 810 | 0.290 |
Why?
|
Bayes Theorem | 4 | 2022 | 2303 | 0.280 |
Why?
|
Glutathione Peroxidase | 1 | 2007 | 255 | 0.270 |
Why?
|
Alleles | 5 | 2022 | 6931 | 0.260 |
Why?
|
Breast Neoplasms | 6 | 2010 | 20774 | 0.260 |
Why?
|
Genes, BRCA2 | 1 | 2008 | 617 | 0.250 |
Why?
|
Metformin | 2 | 2023 | 829 | 0.250 |
Why?
|
Humans | 49 | 2024 | 742088 | 0.250 |
Why?
|
Penetrance | 2 | 2022 | 380 | 0.220 |
Why?
|
Insulin | 4 | 2022 | 6575 | 0.220 |
Why?
|
Germ-Line Mutation | 2 | 2007 | 1786 | 0.220 |
Why?
|
Kidney Diseases, Cystic | 1 | 2023 | 186 | 0.210 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6454 | 0.200 |
Why?
|
Models, Genetic | 2 | 2018 | 3493 | 0.200 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2014 | 2195 | 0.190 |
Why?
|
Chromatin | 2 | 2024 | 2917 | 0.170 |
Why?
|
Genetic Markers | 2 | 2018 | 2633 | 0.160 |
Why?
|
Founder Effect | 1 | 2018 | 190 | 0.160 |
Why?
|
Chromosome Mapping | 2 | 2021 | 4742 | 0.160 |
Why?
|
Obesity | 5 | 2023 | 12705 | 0.150 |
Why?
|
Databases, Genetic | 3 | 2021 | 1780 | 0.150 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 24913 | 0.150 |
Why?
|
Glucose Tolerance Test | 1 | 2020 | 1150 | 0.150 |
Why?
|
Risk Factors | 10 | 2023 | 72145 | 0.150 |
Why?
|
Neoplasm Proteins | 1 | 2009 | 3691 | 0.150 |
Why?
|
Intra-Abdominal Fat | 1 | 2022 | 591 | 0.150 |
Why?
|
Chromosomes, Human, X | 1 | 2018 | 296 | 0.140 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 602 | 0.140 |
Why?
|
Oxidative Stress | 1 | 2007 | 3081 | 0.140 |
Why?
|
Risk Assessment | 4 | 2021 | 23320 | 0.130 |
Why?
|
Models, Statistical | 1 | 2010 | 5100 | 0.130 |
Why?
|
Female | 18 | 2024 | 379592 | 0.130 |
Why?
|
Peripheral Arterial Disease | 2 | 2024 | 1184 | 0.120 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2015 | 0.120 |
Why?
|
Blood Glucose | 3 | 2023 | 6249 | 0.120 |
Why?
|
Lipids | 2 | 2021 | 3302 | 0.120 |
Why?
|
Fetus | 1 | 2020 | 1879 | 0.110 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 1 | 2022 | 26 | 0.100 |
Why?
|
Triglycerides | 1 | 2020 | 2450 | 0.100 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1636 | 0.100 |
Why?
|
Pedigree | 1 | 2020 | 4646 | 0.100 |
Why?
|
Hypoglycemic Agents | 2 | 2023 | 2866 | 0.100 |
Why?
|
Disease Progression | 2 | 2024 | 13256 | 0.100 |
Why?
|
Adult | 8 | 2021 | 213712 | 0.090 |
Why?
|
Pregnancy | 3 | 2020 | 29087 | 0.090 |
Why?
|
Cytochrome P-450 CYP1A1 | 1 | 2009 | 91 | 0.090 |
Why?
|
Sex Distribution | 1 | 2014 | 2295 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7770 | 0.080 |
Why?
|
Sulfotransferases | 1 | 2009 | 151 | 0.080 |
Why?
|
Metabolomics | 1 | 2017 | 1467 | 0.080 |
Why?
|
Body Mass Index | 3 | 2022 | 12695 | 0.080 |
Why?
|
Age Distribution | 1 | 2014 | 2900 | 0.080 |
Why?
|
Cohort Studies | 4 | 2022 | 40450 | 0.080 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 780 | 0.080 |
Why?
|
Catechol O-Methyltransferase | 1 | 2009 | 245 | 0.080 |
Why?
|
Case-Control Studies | 4 | 2021 | 21719 | 0.080 |
Why?
|
Risk | 1 | 2020 | 9679 | 0.080 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2009 | 473 | 0.080 |
Why?
|
Prospective Studies | 3 | 2022 | 53187 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2023 | 15056 | 0.070 |
Why?
|
Sample Size | 1 | 2010 | 844 | 0.070 |
Why?
|
Glomerular Filtration Rate | 1 | 2014 | 2167 | 0.070 |
Why?
|
Canada | 1 | 2022 | 2061 | 0.070 |
Why?
|
Male | 10 | 2023 | 349538 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15108 | 0.070 |
Why?
|
Prevalence | 1 | 2023 | 15194 | 0.070 |
Why?
|
Sampling Studies | 1 | 2007 | 623 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3428 | 0.070 |
Why?
|
Estrogen Receptor alpha | 1 | 2009 | 577 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2008 | 11039 | 0.070 |
Why?
|
Linkage Disequilibrium | 1 | 2010 | 1995 | 0.060 |
Why?
|
Carcinoma, Lobular | 1 | 2009 | 484 | 0.060 |
Why?
|
Sleep | 1 | 2021 | 4604 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 3239 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12958 | 0.060 |
Why?
|
Middle Aged | 7 | 2021 | 213127 | 0.060 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4328 | 0.060 |
Why?
|
Haplotypes | 1 | 2010 | 2781 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5611 | 0.060 |
Why?
|
Enteroendocrine Cells | 1 | 2024 | 65 | 0.060 |
Why?
|
Glipizide | 1 | 2023 | 47 | 0.060 |
Why?
|
Prognosis | 3 | 2009 | 29010 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 9941 | 0.060 |
Why?
|
Diet | 1 | 2021 | 7923 | 0.060 |
Why?
|
Lipid Metabolism | 2 | 2021 | 1887 | 0.050 |
Why?
|
Mutation | 3 | 2022 | 29717 | 0.050 |
Why?
|
Hypertension | 1 | 2022 | 8455 | 0.050 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2009 | 1101 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2502 | 0.050 |
Why?
|
Nuclear Proteins | 2 | 2021 | 5851 | 0.050 |
Why?
|
Reactive Oxygen Species | 1 | 2007 | 2077 | 0.040 |
Why?
|
Databases, Factual | 1 | 2014 | 7716 | 0.040 |
Why?
|
Antioxidants | 1 | 2007 | 1659 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2906 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 527 | 0.040 |
Why?
|
Subcutaneous Fat | 1 | 2022 | 391 | 0.040 |
Why?
|
Sweden | 1 | 2021 | 1343 | 0.040 |
Why?
|
Epigenomics | 1 | 2024 | 902 | 0.040 |
Why?
|
Analysis of Variance | 1 | 2007 | 6365 | 0.040 |
Why?
|
Cysts | 1 | 2023 | 676 | 0.040 |
Why?
|
Aged | 5 | 2021 | 162944 | 0.040 |
Why?
|
Internet | 1 | 2010 | 3062 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2024 | 1351 | 0.040 |
Why?
|
Waist Circumference | 1 | 2021 | 917 | 0.040 |
Why?
|
Adipocytes | 1 | 2024 | 1182 | 0.040 |
Why?
|
Diabetic Nephropathies | 1 | 2024 | 983 | 0.040 |
Why?
|
Genetics, Population | 1 | 2021 | 933 | 0.040 |
Why?
|
Child | 2 | 2021 | 77478 | 0.030 |
Why?
|
Mendelian Randomization Analysis | 1 | 2022 | 963 | 0.030 |
Why?
|
Incidence | 1 | 2014 | 20928 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 5019 | 0.030 |
Why?
|
United States | 2 | 2022 | 69693 | 0.030 |
Why?
|
Survival Rate | 1 | 2009 | 12773 | 0.030 |
Why?
|
Young Adult | 3 | 2023 | 56350 | 0.030 |
Why?
|
Consensus | 1 | 2023 | 2935 | 0.030 |
Why?
|
Survival Analysis | 1 | 2007 | 10248 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2023 | 2107 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2183 | 0.030 |
Why?
|
Cholesterol | 1 | 2022 | 2895 | 0.030 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12344 | 0.030 |
Why?
|
Adiposity | 1 | 2022 | 1806 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2009 | 16665 | 0.030 |
Why?
|
Birth Weight | 1 | 2020 | 2068 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3587 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2007 | 13029 | 0.030 |
Why?
|
Registries | 1 | 2007 | 8077 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2023 | 3611 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8425 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3455 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4391 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57683 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2022 | 3278 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3518 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1707 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1952 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2009 | 39004 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7167 | 0.020 |
Why?
|
Mice | 2 | 2019 | 81045 | 0.020 |
Why?
|
Liver | 1 | 2021 | 7470 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8541 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2019 | 14554 | 0.010 |
Why?
|
Proteins | 1 | 2018 | 6096 | 0.010 |
Why?
|
Animals | 2 | 2019 | 168561 | 0.010 |
Why?
|
Genomics | 1 | 2017 | 5692 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35070 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 40955 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 77098 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 85649 | 0.010 |
Why?
|
Concepts
(177)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(80)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_